Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-569-5 | CAS number: 7637-07-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Additional information
Measurement of fluoride ion production over a range of pH values (1.2 to 9) indicated a hydrolytic half-life time of less than 30 minutes for boron trifluoride. Subsequent analysis of boric acid by titration confirmed the rapidity of the reaction. Consequently, when no data is available, the risk associated to dehydrated boron trifluoride when release into water can be assessed based upon the hazards of its breakdown products in water: boric acid and fluoboric acid.
With regards to boric acid,the preliminary study showed that at each of pH 1.2, 4, 7 and 9 and 50±0.5ºC, less than 10% hydrolysis had occurred after 5 days, equivalent to a half-life of greater than 1 year under environmental conditions (25°C). ThusBoric acid was determined to be hydrolytically stable under acidic, neutral and basic conditions.
With regards to tetrafluoroborate, it is apparent thattetrafluoroborate hydrolyses under environmental conditions, forming boric acid and, predominantly, partially hydrolysed fluoroborate species (i.efluorine and hydronium ions). HF is not expected at significant amounts as it occurs in the systemic circulation only as free ionic or as organically bound fluoride.
In conclusion boric acid is the predominant and most stable breakdown product of boron trifluoride
H3BO3
Boric acid is classified R60 and R61, a CMR category 2 according to the directive 67/548/EEC. Indeed several repeated oral exposures of mice, rats and dogs to borates have shown evidence of damage to the testes and repeated oral exposure of pregnant mice, rats and rabbits to borates have shown developmental toxicity. The key studies used in European risk assessment (2007) and for the classification of this substance are as follows:
- Weir RJ Jr, Fisher RS.; Toxicologic studies on borax and boric acid; Toxicol Appl Pharmacol. 1972 Nov;23(3):351-64.
The no-effect-level (NOAEL) in this study is 17 mg Boron/kg bw/day (equivalent to 97 mg/kg bw/day boric acid), based on effects observed in the rat testes during a 3 generation dietary study.
- Price CJ, Strong PL, Marr MC, Myers CB, Murray FJ.; Developmental toxicity NOAELand postnatal recovery in rats fed boric acid during gestation.; Fundam Appl Toxicol. 1996 Aug;32(2):179-93.
In this study, the NOAEL for developmental effects (reduction in foetal body weight and skeletal malformations) is 9.6 mg Boron/kg bw/day (equivalent to 55 mg/kg bw/day boric acid) in pregnant rats exposed to boric acid from days 0 to 20 of the gestation period.
Therefore, the reprotoxicity potential of BF3 has to be considered. Nevertheless, as the substance is very toxic by inhalation (classified R 26) it seems reasonable to consider that the parental toxicity - especially severe respiratory irritation tract - would occur at dose levels well below a predictable reprotoxicity (see below).
Extrapolation of the BF3 NOAEC for reproductive effects
In order to compare the dose-levels of BF3 that would lead to possible reproductive effects and those leading to severe respiratory tract irritation (studies in rats), boric acid NOAELs were converted into theoretical inhalation NOAECs of BF3:
One mole of BF3 is assumed to be transformed into one mole of H3BO3.
Following molecular weights (MW) were used:
MW for Boron: 10.81 g/mol
MW for Fluorine: 19 g/mol
MW for Hydrogen: 1g/mol
MW Oxygen: 16 g/mol
One mole of BF3(67.81 g) <-- > one mole of H3BO3(61.51 g)
Then:
97 mg/kg bw/day boric acid <-- > 106.9 mg/kg bw/day BF3
55 mg/kg bw/day boric acid <-- > 60 mg/kg bw/day BF3
Considering that NOAELrat x ABSoral/rat = NOAECrat x ABSinh/rat x sRVrat
(SRVrat is the standard respiratory volume for 6 hours duration), then:
NOAEC = (NOAELrat x ABSoral/rat)/ (ABSinh/rat x sRVrat)
No data is available for ABSoral/rat and ABS inh/rat; therefore a worst case was used, as proposed in ECHA’s R8 guidance document: ABSoral/rat is 50 % and ABS inh/rat is 100%. SRVrat is 0.29 m3/kg bw
Therefore:
- virtually BF3NOAEC for effects on fertility = (97 x 50)/(100 x 0.29) = 167.2 mg/m3
- virtually BF3NOAEC for effects on development = (55 x 50)/(100 x 0.29) = 94.8 mg/m3
These concentrations are near those at which mortality or severe respiratory distress were observed in repeated inhalation exposure for 2 weeks (Rusch et al., 1986). In this study, rats exposed to 180 mg/m3of BF3were all dead prior to the sixth exposure. At 66 mg/m3, no mortality occurred but respiratory distress, reduction of mean body weights and increase of lung weights were observed, without any histopathological changes, including no changes in testis.
Moreover it should be noted that
- worst case assumption has been made in order to obtain virtually NOAEC for fertility and development, since ABSoral/rat was chosen as twice more than ABSinh/rat.
- the prenatal study with boric acid was done via gavage. This leads to a much higher peak concentration of boric acid in plasma and foetus than after inhalation over 6 hrs.
- BF3,H2O did not show any signs on reproductive organs in the 90-days toxicity study (Rusch, 1986 – equivalent to OECD 413), for levels of 17 mg/m3(highest tested concentration)
In conclusion, with BF3exposure, severe parental toxicity would be observed well before effects on fertility and on development. For this reason, any reproductive study with BF3is scientifically unjustified.
References:
ATSDR Toxicological Profile for Fluorides, Hydrogen Fluoride and Fluorine, September 2003
Documentations for classification of boric acid:
http://ecb.jrc.ec.europa.eu/documentation/then Classification and labelling/Background documentation to boron
Price CJ, Strong PL, Marr MC, Myers CB, Murray FJ.;Developmental toxicity NOAEL and postnatal recovery in rats fed boric acid during gestation.; Fundam Appl Toxicol. 1996 Aug;32(2):179-93.
Weir RJ Jr,Fisher RS.; Toxicologic studies on borax and boric acid;Toxicol Appl Pharmacol.1972 Nov;23(3):351-64.
G.M.Rusch et al., Inhalation toxicity studies with Boron Trifluoride. Toxicol. Apppl. Pharmacol., 83 (1), 69-78, 1986.
European Union Risk Assessment Report on Boric Acid (2007)
European Union Risk Assessment Report on HF (2001)
Short description of key information:
No experimental study is available. Nevertheless, severe parental toxicity would be observed after exposure to BF3, well before effects on fertility induced by hydrolysis product in human body, boric acid. For this reason, any reproductive study with BF3 is scientifically unjustified.
Effects on developmental toxicity
Description of key information
No experimental study is available. Nevertheless, severe parental toxicity would be observed after exposure to BF3, well before developmental effects induced by hydrolysis product in human body, boric acid. For this reason, any reproductive study with BF3 is scientifically unjustified.
Additional information
See the discussion above in the § fertility.
Justification for classification or non-classification
According to EU directive 67/548/EEC and EU Regulation (EC) N0. 1272/2008 (CLP), the substance is not classified for reproductive effects.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.